To investigate whether inhibiting the DNA Damage Response (DDR) could ameliorate cardiac dysfunction and affect IFI16 levels in our doxorubicin-induced Dilated Cardiomyopathy (DCM) model, mice were treated with the DNA-PKcs inhibitor NU7441 or vehicle (PBS). Here, PRKDC is linked to dilated cardiomyopathy.